Skip to main content
Erschienen in: Supportive Care in Cancer 4/2012

01.04.2012 | Original Article

Palliative care consultation in pediatric oncology

verfasst von: Donna L. Johnston, Christina Vadeboncoeur

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pediatric oncology patients benefit from the involvement of palliative care. This study examined the timing of palliative care consultation.

Methods

A retrospective chart review was performed on all children from the Children’s Hospital of Eastern Ontario with a diagnosis of malignancy.

Results

Since 2006, 50 children with cancer were referred to palliative care. The mean time of referral after diagnosis was 461 days, with 8(16%) referred within 30 days of diagnosis, 13(26%) before a relapse occurred, 20(40%) after the first relapse, and 9(18%) after ≥2 relapses. Of the 40 patients referred to palliative care who died, 28% died at home, 30% in hospital, and 43% in hospice. Of the 49 oncology patients who died during the study period, 88% received a palliative care consult prior to death.

Conclusions

The majority of children in this study who died from cancer were referred to palliative care. Oncologists should strive to refer patients early in their disease.
Literatur
1.
Zurück zum Zitat Field MJ, Behrman R (2003) When children die: improving palliative and end-of-life care for children and their families. National Academies Press, Washington D.C., pp 19–71 Field MJ, Behrman R (2003) When children die: improving palliative and end-of-life care for children and their families. National Academies Press, Washington D.C., pp 19–71
2.
Zurück zum Zitat Himelstein BP (2005) Palliative care in pediatrics. Anesthesiol Clin North America 23:837–856PubMedCrossRef Himelstein BP (2005) Palliative care in pediatrics. Anesthesiol Clin North America 23:837–856PubMedCrossRef
3.
Zurück zum Zitat Thompson LA, Knapp C, Madden V, Shenkman E (2002) Pediatricians’ perceptions of and preferred timing for pediatric palliative care. Pediatrics 123:e777–782CrossRef Thompson LA, Knapp C, Madden V, Shenkman E (2002) Pediatricians’ perceptions of and preferred timing for pediatric palliative care. Pediatrics 123:e777–782CrossRef
4.
Zurück zum Zitat Zhukovsky DS, Herzog CE, Kaur G, Palmer JL, Bruera E (2009) The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med 12:343–349PubMedCrossRef Zhukovsky DS, Herzog CE, Kaur G, Palmer JL, Bruera E (2009) The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med 12:343–349PubMedCrossRef
5.
Zurück zum Zitat Wolfe J, Hammel JF, Edwards EK, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC (2008) Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol 26:1717–1723PubMedCrossRef Wolfe J, Hammel JF, Edwards EK, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC (2008) Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol 26:1717–1723PubMedCrossRef
6.
Zurück zum Zitat Widger K, Davies D, Drouin DJ, Beaune L, Daoust L, Farran RP, Humbert N, Nalewajek F, Rattray M, Rugg M, Bishop M (2007) Pediatric patients receiving palliative care in Canada. Arch Pediatr Adolesc Med 161:597–602PubMedCrossRef Widger K, Davies D, Drouin DJ, Beaune L, Daoust L, Farran RP, Humbert N, Nalewajek F, Rattray M, Rugg M, Bishop M (2007) Pediatric patients receiving palliative care in Canada. Arch Pediatr Adolesc Med 161:597–602PubMedCrossRef
7.
Zurück zum Zitat Committee B, Society CP (2008) Advance care planning for paediatric patients. Pediatr Child Health 13:791–96 Committee B, Society CP (2008) Advance care planning for paediatric patients. Pediatr Child Health 13:791–96
8.
Zurück zum Zitat American Academy of Pediatrics, Committee on Bioethics and Committee on Hospital Care (2000) Palliative care for children. Pediatrics 106:351–357CrossRef American Academy of Pediatrics, Committee on Bioethics and Committee on Hospital Care (2000) Palliative care for children. Pediatrics 106:351–357CrossRef
9.
Zurück zum Zitat Himelstein BP, Hilden JM, Boldt AM, Weissman D (2004) Pediatric palliative care. N Engl J Med 350:1752–1762PubMedCrossRef Himelstein BP, Hilden JM, Boldt AM, Weissman D (2004) Pediatric palliative care. N Engl J Med 350:1752–1762PubMedCrossRef
10.
Zurück zum Zitat Vadeboncoeur CM, Splinter WM, Rattray M, Johnston DL, Coulombe L (2010) A paediatric palliative care programme in development: trends in referral and location of death. Arch Dis Child 95:686–689PubMedCrossRef Vadeboncoeur CM, Splinter WM, Rattray M, Johnston DL, Coulombe L (2010) A paediatric palliative care programme in development: trends in referral and location of death. Arch Dis Child 95:686–689PubMedCrossRef
11.
Zurück zum Zitat Johnston DL, Nagel K, Friedman DL, Meza JL, Hurwitz CA, Friebert S (2008) Availability and utilization of palliative care and end-of-life services for pediatric oncology patients: A report from the Children’s Oncology Group Palliative Care Committee. J Clin Oncol 26:4646–4650PubMedCrossRef Johnston DL, Nagel K, Friedman DL, Meza JL, Hurwitz CA, Friebert S (2008) Availability and utilization of palliative care and end-of-life services for pediatric oncology patients: A report from the Children’s Oncology Group Palliative Care Committee. J Clin Oncol 26:4646–4650PubMedCrossRef
12.
Zurück zum Zitat Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B, Furman WL, Hinds PS (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatrics 121:1301–1309CrossRef Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B, Furman WL, Hinds PS (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatrics 121:1301–1309CrossRef
13.
Zurück zum Zitat Wolfe J, Grier H, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 343:326–333CrossRef Wolfe J, Grier H, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 343:326–333CrossRef
Metadaten
Titel
Palliative care consultation in pediatric oncology
verfasst von
Donna L. Johnston
Christina Vadeboncoeur
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1152-6

Weitere Artikel der Ausgabe 4/2012

Supportive Care in Cancer 4/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.